Blog

Hedge Fund Ranking 2014

12 January 2016

Russian SPEAR’s rating of hedge-funds loses its actuality and value due to  delays and mistakes. For instance, the last SPEAR’s rating  doesn’t provide information about hedge-funds for the 2014 year because it is hard for  prospective clients  to give value to  an opportunity of the investments . I decided to write the research paper about the HedgeCo ratings of hedge-funds. The HedgeCo  ratings provide  information for about 5 000 hedge-funds.

Let’s start with  the TOP-10 for 2014 HedgeCo rating.

¹

Name

Annual Return

1

Golden Point Capital Management, LLC

Inception: June 2012 / Fund styles[1]: Futures

Location: Chicago, US

93,81%

2

RenovatioFundLP

Inception: June 2013 / Fund styles: Futures

Location: Las-Vegas, US

89,61%

3

OdysseusFundLP

Inception: January 2010 / Fund styles: Long-Short & Aggressive Growth

Location: Tualatin, US

87,17%

4

venBioSelectFundLLC  

Inception: July 2010  /  Fund styles:  Long-Short & Health Care 
Location: San Francisco, US

73,61%

5

venBioSelectFundLtd  

Inception: July 2010  /  Fund styles:  Long-Short & Health Care 
Location: San Francisco, US

73,48%

6

QuanTechnologyFund  

Inception: October 2009  / Fund styles:  Long-Short & Technology 
Location: Cayman Islands

72%

7

ArquitosCapitalPartners, LP 

Inception: April 2012  /  Fund styles:  Fundamental & Long 
Location: Koronado, US

57,77%

8

SpektraFund, LP

Inception: January 2013 / Fund styles:  Fundamental & Events

Location: Kirkland, US

47,06%

9

HaidarJupiterFundLLC

Inception: September 2000  /  Fund styles:  Global Macro & Aggressive Growth 
Location: New-York, US

45,71

10

CenturionIncomeFundI, LLP

Inception: August 2013 Fund styles: Options/Bonds

Îôèñ: Draper, US

41,95%

9 of  10 funds have existed less than 5 years in the market and they are from the USA. The biggest quantity of hedge funds is American. The table presents  information about those hedge funds with the best annual return for 2014. The most  interesting rating is the one  about the return for the period from the years 2012 to 2014. Three years is the minimum recommended period for investments into hedge-fund.

¹

Name

Annual Return

1

venBioSelectFundLLC  

Inception: July 2010  /  Fund styles:  Long-Short & Health Care 
Location: San Francisco, US

333,61%

2

venBioSelectFundLtd  

Inception: July 2010  /  Fund styles:  Long-Short & Health Care 
Location: San Francisco, US

328,67%

3

Renovatio Fund LP

Inception: June 2013 / Fund styles: Futures

Location: Las-Vegas, US

289,38%

4

TheVilasFund, LP

Inception: August 2010  Fund styles:  Fundamental 
Location: Chicago, US

244,31%

5

The Rhino Small-Cap Financial Fund

Inseption: July 2011 / Fund styles:  Long-Short  & Finance 
Location: Pensilvania, US

216,61%

6

KrensavagePartners, LP  

Inception: July 2008  Fund styles:  Health Care & Long-Short 
Location: New-York, US

213,56%

7

KineticsSmallCapPartners, LP

Inception: August 2007  Fund styles:  Long-Short 
Location: Elmsford, US

211,59%

8

Odysseus Fund LP

Inception: January 2010 / Fund styles: Long-Short & Aggressive Growth

Location: Tualatin, US

198,49%

9

Bayou City Capital, LP

Inception: January 2004 / Fund styles:  Option strategies  & Long 
Location: Houston, US

184,06%

10

Haven Real Estate Focus Fund

Inception: February 2009 / Fund styles:  Long-Short
Location: Oak Brook, US

163,53%

The funds’ rating over  three years shows the range of best return for the TOP-10 funds from 50% to 110% annual return. 4 funds fell within in both ratings. «venBio Select Fund LLC» is the leader of the last rating. In 2014 it takes fifth place. Return distribution of the «venBio Select Fund LLC»  hedge-fund for the three years is as follows:

Period

Annual Return

2014

61,81%

2013

122,41%

2012

20,92%

«venBio Select Fund LLC»   fund invests primarily in equities, debts, and derivatives of  companies  which are operating in the life science industry such as,  biotechnology, pharmaceuticals, lesser degree medical devices and instruments, healthcare services, and healthcare information technology.

Minimum Investments: 1.0M USD

Annual Sharpe Ratio (RFR = 3%): 1.51

Annual Standard Deviation: 26.21%

CAGR: 47,21%

Max. Drawdown: -21.12%

Website: http://www.venbio.com/

The second fund which fell within both ratings is the  «Renovatio Fund LP» hedge- fund. It has worked since July 2013. Return distribution of the «Renovatio Fund LP»  hedge-fund  for the two year period is as follows:

Period

Annual Return

2014

89,61%

2013

105,36%

The fund invests in commodities, futures, options, options on futures, equities, debts and other. The Renovatio Fund combines fundamental macroeconomic analysis (to identify trades) with technical analysis (to identify entry and exit points).

Minimum Investments: 0.250M USD

Annual Sharpe Ratio (RFR = 3%): 1.76

Annual Standard Deviation: 62.71%

CAGR: 147,51%

Max. Drawdown: -35.54%

Website: http://fourthturningcapital.com/

The third fund from both ratings is Odysseus Fund LP. Return distribution of the Odysseus Fund LP»  hedge-fund for the three years is as follows:

Period

Annual Return

2014

83,17%

2013

43,75%

2012

10,94%

The fund uses a fundamental analysis of the companies.

Minimum Investments: 0.250M USD

Annual Sharpe Ratio (RFR = 3%): 0.93

Annual Standard Deviation: 26.51%

CAGR: 27,56%

Max. Drawdown: -18.40%

Website: not found

Results of «Eganov Asset Management Stocks&Derivatives Strategies S.P.» fund’s work in 2014

March 2014  became the important point for my fund for starting option strategies in American exchanges. The fund dropped to 9% due to the situation in  Crimea because all my trading activity was in the Russian exchange. The first cause of the decrease was a big gap down in Russian market on Monday, March 3rd. Secondly, Moscow exchange increased margin level in several times. As a result, our fund could not make hedging trades.  Every cloud has a silver lining and I understand that the Russian crisis  was a good motivation for my fund to switch into the American financial market. In April I halved my trading activity in Russia and started to trade option strategies in Chicago Board Options Exchange (CBOE). In August, I published a new presentation about my hedge-fund in which I gave information about my new team and option strategies. In December I transferred all investments into the  American financial market. The result of  my work the in Russian financial market in comparison with index RTS:

Period

Fund Eganov Asset Management Stocks&Derivatives Strategies S.P

Index RTS

2013

+1,11%

-11,40%

2014

-0,78%

-45,19%

The table shows the return in USD because  the fund and the index RTS is calculated in USD as well. The fund hedged completely the currency risk and avoided the ruble devaluation in  autumn 2014.

As a result of  Eganov Asset Management Stocks&Derivatives Strategies S.P. fund’s work on the Russian market has savings of the capital of the fund in comparison to a drop of the Russian market more than 50% for 2 years. During the last six months of 2014, my fund traded only with profit and completely replaced the decrease of March 2014. The annual return of the fund has been 40% since May 2014 i.e. after the start of trading in the American financial market. Now our team trades  option strategies on the index and on the same futures S&P500[2]. These strategies help to reduce the political and liquidity risk which we had, while trading only in Russia.

With our administrator –company, Apex, we began  to collect data for our annual audit, which will be done by the auditing company Deloitte.  I am going to make a demo-statement for prospective qualified investors to show our stability and transparency.  I am ready to assist every prospective qualified investor with to choose the hedge -fund, and do the paperwork to buy the shares of any hedge-fund.

 

 

 

 



The S&P 500, or the Standard & Poor's 500, is an American stock market index based on the market capitalizations of 500 large companies having common stock listed on the NYSE or NASDAQ. It is one of the most commonly followed equity indices, and many consider it one of the best representations of the U.S. stock market, and a bellwether for the U.S. economy.


Information for investors

This website is provided by Eganov Asset Management Partners (the “Investment Adviser”) and is for information purposes only. No guarantee, representation, undertaking or warranty, express or implied, is given by the Investment Advisor, Emerging Asset Management Ltd (the “Investment Manager”),  Cayman Emerging Manager Platform SPC (the “Company”), Eganov Asset Management Stocks & Derivatives Strategies S.P. (the "Sub-Fund"), Apex Fund Services Ltd (the “Administrator”) or their respective directors, officers, partners, shareholders or members as to the accuracy or completeness of the information or opinions contained on this website and no liability is accepted by such persons for the accuracy or completeness of any such information or opinions.

The Sub-Fund is a Segregated Account constituted as a distinct class of shares in the Company, an exempted segregated portfolio company incorporated in May 2011 for an unlimited duration and is registered as a mutual fund with the Cayman Islands Monetary Authority.

This website does not constitute or form any part of a prospectus, offer, invitation or solicitation for the sale of shares in the Company or the Sub-Fund, nor should it be construed to constitute any investment, legal or tax advice.

It should not be used or considered for the purpose of any offer to sell or solicitation to buy shares in the Company or the Sub-Fund in any jurisdiction or in any circumstances in which such offer or solicitation is unlawful or not authorized. This website is not aimed at persons who are residents of any country in which such an offer or solicitation is not authorized or to any person to whom it is unlawful to make any offer to sell or solicitation to buy shares in the Company or the Sub-Fund.

Users of this website who intend to subscribe for shares in the Company or the Sub-Fund are reminded that any subscription for any class of shares in the Company or the Sub-Fund can only be made by completing the subscription agreement for the relevant shares and shall be made solely on the basis of the information contained in the private placement memorandum of the Company and the supplement thereto of the Sub-Fund.  

Persons interested in making a subscription into the shares of the Company or the Sub-Fund should contact the Investment Advisor for the necessary documentation.

In making an investment decision, investors must rely on their own examination of the Company and the Sub-Fund and the terms of the offering, including the merits and risks involved. No assurance can be given that the Company’s or the Sub-Fund’s investment objectives will be achieved.

The shares of the Company or the Sub-Fund have not been filed with or approved or disapproved by any regulatory authority of any country or other jurisdiction, nor has any such regulatory authority passed upon or endorsed the merits of the Company or the Sub-Fund.

The directors of the Company (the "Directors") do not expect that an active secondary market will develop in the Company’s or the Sub-Fund’s shares. No listing or other dealing facility is at present being sought for any part of the Company’s or the Sub-Fund’s shares, although the Directors may reserve the right to seek a listing in the future.

Information for investors in the Russian Federation

Users of this website are reminded that no approval has been sought in relation to the Company or the Sub-Fund from any regulatory body in the Russian Federation. In the RF, the shares of the Company or the Sub-Fund can only be sold after obtaining the approval of the Federal Commission of the Security Market, which has not been obtained, and then only subject to requirements provided in law.

Information for investors in the Republic of Cyprus

Users of this website are reminded that no approval has been sought in relation to the Company or the Sub-Fund from any regulatory body in the Republic of Cyprus. In the Republic of Cyprus, the shares of the Company or the Sub-Fund can only be sold after obtaining the approval of the CySEC, which has not been obtained, and then only subject to requirements provided in law.

Information for investors in the United Arab Emirates

Users of this website are reminded that no approval has been sought in relation to the Company or the Sub-Fund from any regulatory body in the UAE. In the UAE, the shares of the Company or the Sub-Fund can only be sold after obtaining the approval of the Emirates Securities and Commodities Authority, which has not been obtained, and then only subject to requirements provided in law.

Information for investors in the United Kingdom

Users of this website are reminded that the Company or the Sub-Fund is not authorized or regulated under the provisions of the Financial Services and Market Act 2000. Accordingly, the shares of the Company or the Sub-Fund cannot be promoted or sold in the United Kingdom, other than under the exemptions permitted by the Act, in particular, the Financial Services and Market Act 2000 (Participation of Collective Investment Schemes) (Exemptions) Order 2001. In the UK, the shares of the Company or the Sub-Fund can only be sold to professional clients and/or self certified sophisticated high net worth individuals by an FSA Regulated Investment Advisor who has carried out a suitability test, as this is classified as an Unregulated Collective Investment Scheme ("UCIS") and is not regulated or recognized by the FSA in the United Kingdom.

Information for investors in the United States of America

Users of this website are reminded that the shares of the Company or the Sub-Fund may not be offered or sold in the United States or to U.S. persons at any time (as defined in Regulation S under the U.S. Securities Act of 1933 or the U.S. Internal Revenue Code). The shares of the Company or the Sub-Fund have not been and will not be registered under the U.S. Securities Act of 1933, as amended, or the securities laws of any state in the United States, and is subject to U.S. tax requirements. The shares of the Company or the Sub-Fund may not be offered, sold, transferred or delivered without compliance with all applicable securities laws and regulations.

Information for investors in Cayman Islands

Users of this website are reminded that the Company or the Sub-Fund may not make an invitation to the public in Cayman Islands to subscribe for the shares of the Company or the Sub-Fund.

No investment, legal or tax advice

Nothing contained in this website constitutes investment, legal, tax or other advice, nor is it to be relied upon when making investment or other decisions. The information on this website is available for information purposes only. You should obtain relevant and specific professional and legal advice before making any decision to enter into an investment transaction.

Liability for use of this website

Access to this website is permitted on a temporary basis and the Investment Advisor reserves the right to withdraw or amend the service it provides on this website without notice. The material and information displayed on this website are provided without any guarantees, conditions or warranties as to accuracy or completeness and are not intended to amount to advice on which reliance should be placed. The Investment Advisor, the Investment Manager, the Administrator, the Company and the Sub-Fund disclaim all liability and responsibility arising from any reliance placed on such materials and information contained on this website, or by anyone informed of any of this website's contents.

The internet is not a completely reliable transmission medium and none of the Investment Advisor, the Investment Manager, the Administrator, the Company and the Sub-Fund accept any liability for any data transmission errors such as data loss or damage or alteration of any kind or for the security or confidentiality of information transmitted across the internet to or from the Investment Advisor, the Investment Manager, the Administrator, the Company, the Sub-Fund or their respective directors, officers, partners, shareholders or members. Any such transmission of information is entirely at the website user's own risk.

Intellectual property rights

The Investment Advisor is the owner or the licensee of all intellectual property rights in this website, and in the materials published on it. Those works are protected by laws and treaties around the world. All such rights are reserved. Information found on this website may not be reproduced, distributed, stored in a data retrieval system, linked to modified or transmitted, in any forms or by any means (electronic, mechanical, photocopying, recording, or otherwise) without the prior written consent of the Investment Advisor. Nothing on this website can be construed as granting any license or right in relation to any of the Investment Advisors trademarks or those of a third party.

Law and variation

The terms and use of this website are governed by and shall be construed in accordance with the laws of Cayman Island. The courts of Cayman Island will have jurisdiction over any dispute arising from, or related to this website and by using this website each user agrees that the courts of Cayman Island are the most appropriate and convenient courts to settle disputes. Accordingly, each user agrees not to argue to the contrary or object to proceedings in such courts on the grounds of venue or that the proceedings have been brought in an inconvenient forum. The Investment Advisor retains the right to bring, in its sole discretion, proceedings against any user for any breach of these terms in the user's country of residence or any other relevant country.